Antihemophilic factor, human recombinant Completed Phase 4 Trials for Hemophilia A Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT02170402China ADVATE PTP Study